| Title |
Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease: The TEAM-AD VA Cooperative Randomized Trial
|
|---|---|
| Published in |
JAMA: Journal of the American Medical Association, January 2014
|
| DOI | 10.1001/jama.2013.282834 |
| Pubmed ID | |
| Authors |
Maurice W. Dysken, Mary Sano, Sanjay Asthana, Julia E. Vertrees, Muralidhar Pallaki, Maria Llorente, Susan Love, Gerard D. Schellenberg, J. Riley McCarten, Julie Malphurs, Susana Prieto, Peijun Chen, David J. Loreck, George Trapp, Rajbir S. Bakshi, Jacobo E. Mintzer, Judith L. Heidebrink, Ana Vidal-Cardona, Lillian M. Arroyo, Angel R. Cruz, Sally Zachariah, Neil W. Kowall, Mohit P. Chopra, Suzanne Craft, Stephen Thielke, Carolyn L. Turvey, Catherine Woodman, Kimberly A. Monnell, Kimberly Gordon, Julie Tomaska, Yoav Segal, Peter N. Peduzzi, Peter D. Guarino |
| Abstract |
Although vitamin E and memantine have been shown to have beneficial effects in moderately severe Alzheimer disease (AD), evidence is limited in mild to moderate AD. |
X Demographics
The data shown below were collected from the profiles of 264 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 68 | 26% |
| Spain | 16 | 6% |
| Japan | 12 | 5% |
| Canada | 11 | 4% |
| United Kingdom | 10 | 4% |
| Netherlands | 8 | 3% |
| Mexico | 5 | 2% |
| Turkey | 4 | 2% |
| Italy | 4 | 2% |
| Other | 27 | 10% |
| Unknown | 99 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 200 | 76% |
| Practitioners (doctors, other healthcare professionals) | 36 | 14% |
| Scientists | 22 | 8% |
| Science communicators (journalists, bloggers, editors) | 6 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 645 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | <1% |
| Spain | 2 | <1% |
| United Kingdom | 1 | <1% |
| Canada | 1 | <1% |
| Australia | 1 | <1% |
| Singapore | 1 | <1% |
| Portugal | 1 | <1% |
| Guatemala | 1 | <1% |
| Mexico | 1 | <1% |
| Other | 0 | 0% |
| Unknown | 631 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 126 | 20% |
| Student > Master | 86 | 13% |
| Researcher | 66 | 10% |
| Student > Ph. D. Student | 58 | 9% |
| Student > Postgraduate | 41 | 6% |
| Other | 133 | 21% |
| Unknown | 135 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 185 | 29% |
| Agricultural and Biological Sciences | 80 | 12% |
| Nursing and Health Professions | 38 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 38 | 6% |
| Biochemistry, Genetics and Molecular Biology | 31 | 5% |
| Other | 112 | 17% |
| Unknown | 161 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 837. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 September 2023.
All research outputs
#22,105
of 25,654,806 outputs
Outputs from JAMA: Journal of the American Medical Association
#538
of 36,682 outputs
Outputs of similar age
#140
of 320,719 outputs
Outputs of similar age from JAMA: Journal of the American Medical Association
#5
of 325 outputs
Altmetric has tracked 25,654,806 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 36,682 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 72.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 320,719 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 325 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.